Targeting mitochondrial apoptosis to overcome treatment resistance in cancer
10.3390/cancers12030574
Saved in:
Main Authors: | Ngoi N.Y.L., Choong C., Lee J., Bellot G., Wong A.L.A., Goh B.C., Pervaiz S. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Review |
Published: |
MDPI AG
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/169447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Understanding phosphatidylinositol 3-kinase independent survival pathways in the prostate cancer model, LNCaP
by: TEONG HUEY FERN
Published: (2010) -
Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells
by: Kumar, J.K., et al.
Published: (2014) -
Apoptosis signaling in cancer stem cells
by: Fulda, S., et al.
Published: (2011) -
Proteins of the Bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities
by: Chan, S.-L., et al.
Published: (2014) -
Chelerythrine and sanguinarine dock at distinct sites on Bcl(XL) that are not the classic BH3 binding cleft
by: Zhang, Yong-Hong, et al.
Published: (2020)